- Home
- EMD vs NPCE Comparison
EMD vs NPCE Comparison
Compare EMD & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMD
- NPCE
- Stock Information
- Founded
- EMD 2003
- NPCE 1997
- Country
- EMD United States
- NPCE United States
- Employees
- EMD N/A
- NPCE N/A
- Industry
- EMD Finance/Investors Services
- NPCE Medical Specialities
- Sector
- EMD Finance
- NPCE Health Care
- Exchange
- EMD Nasdaq
- NPCE Nasdaq
- Market Cap
- EMD 527.7M
- NPCE 424.1M
- IPO Year
- EMD N/A
- NPCE 2021
- Fundamental
- Price
- EMD $9.90
- NPCE $10.41
- Analyst Decision
- EMD
- NPCE Buy
- Analyst Count
- EMD 0
- NPCE 7
- Target Price
- EMD N/A
- NPCE $15.14
- AVG Volume (30 Days)
- EMD 248.5K
- NPCE 408.2K
- Earning Date
- EMD 01-01-0001
- NPCE 08-12-2025
- Dividend Yield
- EMD 10.25%
- NPCE N/A
- EPS Growth
- EMD N/A
- NPCE N/A
- EPS
- EMD N/A
- NPCE N/A
- Revenue
- EMD N/A
- NPCE $84,306,000.00
- Revenue This Year
- EMD N/A
- NPCE $21.00
- Revenue Next Year
- EMD N/A
- NPCE $11.81
- P/E Ratio
- EMD N/A
- NPCE N/A
- Revenue Growth
- EMD N/A
- NPCE 22.05
- 52 Week Low
- EMD $7.85
- NPCE $5.45
- 52 Week High
- EMD $9.55
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- EMD 66.75
- NPCE 31.48
- Support Level
- EMD $9.75
- NPCE $12.63
- Resistance Level
- EMD $9.85
- NPCE $13.91
- Average True Range (ATR)
- EMD 0.08
- NPCE 0.76
- MACD
- EMD 0.00
- NPCE -0.36
- Stochastic Oscillator
- EMD 91.18
- NPCE 0.85
About EMD Western Asset Emerging Markets Debt Fund Inc
Western Asset Emg Markets Debt Fund Inc is a non-diversified closed-end management investment company. Its primary investment objective is to seek high current income and the secondary objective is to seek capital appreciation.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.